Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently released financial and operational results for the three months ending December 31, 2018. An article discussing the company’s Q2 2019 results reads, “With revenues for the quarter climbing to a fiery run rate of $20.6 million, the company is now one of the top-eight publicly traded Canadian licensed producers. Its Q2 2019 revenue was $7.72 million, marking a 359 percent increase over the $1.68 million of Q2 2018 and a 50 percent increase from Q1 2019 revenues of $5.14 million (http://cnw.fm/5qnQO). This top-of-the-line run rate is set to continue as Supreme Cannabis expands its domestic product delivery channels. In addition, the company recently announced that, after receiving approval from the Depository Trust Company (‘DTC’) of New York, its shares are now DTC eligible. . . . Supreme Cannabis has posted a string of achievements in the last calendar year, showing that it is aptly named. 7ACRES, its wholly owned subsidiary and multiaward-winning brand, was named ‘Brand of the Year’ at the 2018 Canadian Cannabis Awards.”
To view the full article, visit http://cnw.fm/wkKs6
About Supreme Cannabis Company Inc.
Supreme Cannabis is a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people and uniquely innovative culture. The company’s portfolio includes its wholly-owned subsidiary and multiaward-winning brand, 7ACRES. 7ACRES is a federally licensed producer of cannabis operating inside a 440,000-square-foot facility in Kincardine, Ontario. 7ACRES is dedicated to providing consumers with a premium-quality product that recognizes its customers are informed and discerning, and value a brand and culture that aligns with their principles. The brand success of 7ACRES has been reflected in its Brand of the Year award at the 2018 Canadian Cannabis Awards and Best Licensed Producer Branding award at the 2018 AdCann Advertising Awards, as well as in provincial supply agreements where 7ACRES’ product is consistently listed in the highest brand category available to recreational consumers. The company’s growing portfolio also includes an equity investment and long-term global distribution partnership with Lesotho-based Medigrow for the exporting of medical-grade cannabis oil. Supreme Cannabis has been a leading innovator in the sector including the design of growing facilities and the development of operational excellence metrics. The company is confident that with its flagship brand, proprietary technology and products, along with its unique culture and industry-leading team, it will deliver consistent, long-term value creation to its shareholders. For more information, visit the company’s website at www.Supreme.ca.
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CBDW? Ask our Editor
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com